Diethyldithiocarbamate Suppresses an NF-κB Dependent Metastatic Pathway in Cholangiocarcinoma Cells

  • Srikoon, Pattaravadee (Division of Hematopoiesis, Center for AIDS Research, Kumamoto University) ;
  • Kariya, Ryusho (Division of Hematopoiesis, Center for AIDS Research, Kumamoto University) ;
  • Kudo, Eriko (Division of Hematopoiesis, Center for AIDS Research, Kumamoto University) ;
  • Goto, Hiroki (Division of Hematopoiesis, Center for AIDS Research, Kumamoto University) ;
  • Vaeteewoottacharn, Kulthida (Division of Hematopoiesis, Center for AIDS Research, Kumamoto University) ;
  • Taura, Manabu (Division of Hematopoiesis, Center for AIDS Research, Kumamoto University) ;
  • Wongkham, Sopit (Department of Biochemistry and Liver Fluke and Cholangiocarcinoma Research Center, Faculty of Medicine, Khon Kaen University) ;
  • Okada, Seiji (Division of Hematopoiesis, Center for AIDS Research, Kumamoto University)
  • Published : 2013.07.30


Cholangiocarcinoma (CCA) is a tumor of biliary ducts, which has a high mortality rate and dismal prognosis. Constitutively activation of the transcription factor nuclear factor kappa-B (NF-${\kappa}B$) has been previously demonstrated in CCA. It is therefore a potential target for CCA treatment. Effects of diethyldithiocarbamate (DDTC) on NF-${\kappa}B$-dependent apoptosis induction in cancer have been reported; however, anti-metastasis has never been addressed. Therefore, here the focus was on DDTC effects on CCA migration and adhesiond. Anti-proliferation, anti-migration and anti-adhesion activities were determined in CCA cell lines, along with p65 protein levels and function. NF-${\kappa}B$ target gene expression was determined by quantitative RT-PCR. DDTC inhibited CCA cell proliferation. Suppression of migration and adhesion were observed prior to anti-CCA proliferation. These effects were related to decreased p65, reduction in NF-${\kappa}B$ DNA binding, and impaired activity. Moreover, suppression of ICAM-1 expression supported NF-${\kappa}B$-dependent anti-metastatic effects of DDTC. Taken together, DDTC suppression of CCA migration and adhesion through inhibition of NF-${\kappa}B$ signaling pathway is suggested from the current study. This might be a promising treatment choice against CCA metastasis.




  1. Aggarwal BB (2004). Nuclear factor-kappaB: the enemy within. Cancer Cell, 6, 203-8.
  2. Andrews NC, Faller DV (1991). A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res, 19, 2499.
  3. Basseres DS, Baldwin AS (2006). Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene, 25, 6817-30.
  4. Blechacz B, Komuta M, Roskams T, Gores GJ (2011). Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol, 8, 512-22.
  5. Boberg KM, Schrumpf E (2004). Diagnosis and treatment of cholangiocarcinoma. Curr Gastroenterol Rep, 6, 52-9.
  6. Charbel H, Al-Kawas FH (2012). Cholangiocarcinoma treatment. Curr Gastroenterol Rep, 14, 528-33.
  7. Chen JZ, Zhu JH, Wang XX, et al (2004). Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood. J Mol Cell Cardiol, 36, 233-9.
  8. Chiang AC, Massague J (2008). Molecular basis of metastasis. N Engl J Med, 359, 2814-23.
  9. Cho HJ, Lee TS, Park JB, et al (2007). Disulfiram suppresses invasive ability of osteosarcoma cells via the inhibition of MMP-2 and MMP-9 expression. J Biochem Mol Biol, 40, 1069-76.
  10. Cvek B, Dvorak Z (2007). Targeting of nuclear factor-kappaB and proteasome by dithiocarbamate complexes with metals. Curr Pharm Des, 13, 3155-67.
  11. Dasanu CA, Majumder S, Trikudanathan G (2011). Emerging pharmacotherapeutic strategies for cholangiocarcinoma. Expert Opin Pharmacother, 12, 1865-74.
  12. Eneanya DI, Bianchine JR, Duran DO, Andresen BD (1981). The actions of metabolic fate of disulfiram. Annu Rev Pharmacol Toxicol, 21, 575-96.
  13. Goto H, Kariya R, Shimamoto M, et al (2012). Antitumor effect of berberine against primary effusion lymphoma via inhibition of NF-kappaB pathway. Cancer Sci, 103, 775-81.
  14. Hu XS, Du CQ, Yang L, Yao XY, Hu SJ (2010). Proteasome inhibitor MG132 suppresses number and function of endothelial progenitor cells: involvement of nitric oxide synthase inhibition. Int J Mol Med, 25, 385-92.
  15. Janan M, Proungvitaya S, Limpaiboon T, Proungvitaya T, Roytrakul S, et al (2012). Serum adhesion molecule-1 (icam- 1) as a potential prognostic marker for cholangiocarcinoma patients. Asian Pac J Cancer Prev, 13, 107-14.
  16. Langeland BT, McKinley-McKee JS (1996). The effects of disulfiram on equine hepatic alcohol dehydrogenase and its efficiency against alcoholism: vinegar effect. Alcohol Alcohol, 31, 75-80.
  17. Liang CC, Park AY, Guan JL (2007). In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc, 2, 329-33.
  18. Lovborg H, Oberg F, Rickardson L, et al (2006). Inhibition of proteasome activity, nuclear factor-KappaB translocation and cell survival by the antialcoholism drug disulfiram. Int J Cancer, 118, 1577-80.
  19. Margineanu E, Cotrutz CE, Cotrutz C (2008). Correlation between E-cadherin abnormal expressions in different types of cancer and the process of metastasis. Rev Med Chir Soc Med Nat Iasi, 112, 432-6.
  20. Maruo Y, Gochi A, Kaihara A, et al (2002). ICAM-1 expression and the soluble ICAM-1 level for evaluating the metastatic potential of gastric cancer. Int J Cancer, 100, 486-90.
  21. Matsuno T, Kariya R, Yano S, et al (2012). Diethyldithiocarbamate induces apoptosis in HHV-8-infected primary effusion lymphoma cells via inhibition of the NF-kappaB pathway. Int J Oncol, 40, 1071-8.
  22. Murai R, Yoshida Y, Muraguchi T, et al (2010). A novel screen using the Reck tumor suppressor gene promoter detects both conventional and metastasis-suppressing anticancer drugs. Oncotarget, 1, 252-64.
  23. Pande V, Ramos MJ (2005). NF-kappaB in human disease: current inhibitors and prospects for de novo structure based design of inhibitors. Curr Med Chem, 12, 357-74.
  24. Pang H, Chen D, Cui QC, Dou QP (2007). Sodium diethyldithiocarbamate, an AIDS progression inhibitor and a copper-binding compound, has proteasome-inhibitory and apoptosis-inducing activities in cancer cells. Int J Mol Med, 19, 809-16.
  25. Rosette C, Roth RB, Oeth P, et al (2005). Role of ICAM1 in invasion of human breast cancer cells. Carcinogenesis, 26, 943-50.
  26. Schurigt U, Stopfel N, Huckel M, et al (2005). Local expression of matrix metalloproteinases, cathepsins, and their inhibitors during the development of murine antigen-induced arthritis. Arthritis Res Ther, 7, 174-88.
  27. Seubwai W, Vaeteewoottacharn K, Hiyoshi M, et al (2010). Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-kappaB. Cancer Sci, 101, 1590-5.
  28. Shian SG, Kao YR, Wu FY, Wu CW (2003). Inhibition of invasion and angiogenesis by zinc-chelating agent disulfiram. Mol Pharmacol, 64, 1076-84.
  29. Skrott Z, Cvek B (2012). Diethyldithiocarbamate complex with copper: the mechanism of action in cancer cells. Mini Rev Med Chem, 12, 1184-92.
  30. Suh JJ, Pettinati HM, Kampman KM, O'Brien CP (2006). The status of disulfiram: a half of a century later. J Clin Psychopharmacol, 26, 290-302.
  31. Tang X, Li J, Xin X, Geng M (2006). A new marine-derived sulfated polysaccharide from brown alga suppresses tumor metastasis both in vitro and in vivo. Cancer Biol Ther, 5, 1474-80.
  32. Uthaisar K, Seubwai W, Srikoon P, Vaeteewoottacharn K, Sawanyawisuth K, et al (2012). Cepharanthine suppresses metastatic potential of human cholangiocarcinoma cell lines. Asian Pac J Cancer Prev, 13, 149-54.
  33. Wang F, Zhai S, Liu X, et al (2011). A novel dithiocarbamate analogue with potentially decreased ALDH inhibition has copper-dependent proteasome-inhibitory and apoptosisinducing activity in human breast cancer cells. Cancer Lett, 300, 87-95.
  34. Zhang JJ, Xu ZM, Zhang CM, et al (2011). Pyrrolidine dithiocarbamate inhibits nuclear factor-kappaB pathway activation, and regulates adhesion, migration, invasion and apoptosis of endometriotic stromal cells. Mol Hum Reprod, 17, 175-81.

Cited by

  1. Analysis of Different Ways of Drainage for Obstructive Jaundice Caused by Hilar Cholangiocarcinoma vol.15, pp.14, 2014,
  2. In vitro and In vivo Antitumor Activity of Tiliacorinine in Human Cholangiocarcinoma vol.15, pp.17, 2014,
  3. Current Insights on Cholangiocarcinoma Research: a Brief Review vol.16, pp.4, 2015,
  4. Effect of NF-κB inhibition on chemoresistance in biliary–pancreatic cancer vol.45, pp.12, 2015,
  5. The role of tumour microenvironment: a new vision for cholangiocarcinoma pp.15821838, 2018,